Title

Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial.

Document Type

Journal Article

Publication Date

6-3-2020

Journal

Cardiovascular Diabetology

Volume

19

Issue

1

Inclusive Pages

72

DOI

10.1186/s12933-020-01046-z

Peer Reviewed

1

Open Access

1

Find in your library

Share

COinS